ARTHUR LEE: Open Payments
NPI 1780604868 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 69 payments from 15 companies in 2025. Trend: 2023 $1,140 · 2024 $1,084 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $276 |
| ABBVIE INC. | 12 | $213 |
| GlaxoSmithKline, LLC. | 11 | $177 |
| Novo Nordisk Inc | 7 | $146 |
| Lilly USA, LLC | 4 | $107 |
| Astellas Pharma US Inc | 4 | $96 |
| Abbott Laboratories | 4 | $78 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $33 |
Products named: FARXIGA, UBRELVY, SHINGRIX, Veozah, QULIPTA, Ozempic, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
